Literature DB >> 34583997

Choroid plexus volumetrics and brain inflammation in multiple sclerosis.

Navid Manouchehri1, Olaf Stüve2,3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34583997      PMCID： PMC8501877          DOI： 10.1073/pnas.2115221118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  22 in total

1.  Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels.

Authors:  P Vajkoczy; M Laschinger; B Engelhardt
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro.

Authors:  B J Steffen; G Breier; E C Butcher; M Schulz; B Engelhardt
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

3.  Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

Authors:  Maria del Pilar Martin; Petra D Cravens; Ryan Winger; Elliot M Frohman; Michael K Racke; Todd N Eagar; Scott S Zamvil; Martin S Weber; Bernhard Hemmer; Nitin J Karandikar; B K Kleinschmidt-DeMasters; Olaf Stüve
Journal:  Arch Neurol       Date:  2008-10-13

Review 4.  Ulcerative colitis.

Authors:  Taku Kobayashi; Britta Siegmund; Catherine Le Berre; Shu Chen Wei; Marc Ferrante; Bo Shen; Charles N Bernstein; Silvio Danese; Laurent Peyrin-Biroulet; Toshifumi Hibi
Journal:  Nat Rev Dis Primers       Date:  2020-09-10       Impact factor: 52.329

5.  Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans.

Authors:  Vinzenz Fleischer; Gabriel Gonzalez-Escamilla; Dumitru Ciolac; Philipp Albrecht; Patrick Küry; Joel Gruchot; Michael Dietrich; Christina Hecker; Thomas Müntefering; Stefanie Bock; Mohammadsaleh Oshaghi; Angela Radetz; Manuela Cerina; Julia Krämer; Lydia Wachsmuth; Cornelius Faber; Hans Lassmann; Tobias Ruck; Sven G Meuth; Muthuraman Muthuraman; Sergiu Groppa
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

6.  Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment.

Authors:  Navid Manouchehri; Olaf Stüve
Journal:  Ther Adv Neurol Disord       Date:  2021-02-01       Impact factor: 6.570

7.  Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE.

Authors:  Veit Rothhammer; Sylvia Heink; Franziska Petermann; Rajneesh Srivastava; Malte C Claussen; Bernhard Hemmer; Thomas Korn
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

8.  MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune Encephalomyelitis.

Authors:  Kristina Kuhbandner; Anna Hammer; Stefanie Haase; Elisa Terbrack; Alana Hoffmann; Angela Schippers; Norbert Wagner; Rehana Z Hussain; William A Miller-Little; Andrew Y Koh; Joshua S Stoolman; Benjamin M Segal; Ralf A Linker; Olaf Stüve
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

9.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Authors:  Chris H Polman; Paul W O'Connor; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; J Theodore Phillips; Fred D Lublin; Gavin Giovannoni; Andrzej Wajgt; Martin Toal; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

10.  Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study.

Authors:  Geert D'Haens; Séverine Vermeire; Harald Vogelsang; Matthieu Allez; Pierre Desreumaux; Andre Van Gossum; William J Sandborn; Daniel C Baumgart; Richard M Ransohoff; Gail M Comer; Alaa Ahmad; Fabio Cataldi; John Cheng; Robert Clare; Kenneth J Gorelick; Annamarie Kaminski; Vivek Pradhan; Sunday Rivers; Matthew O Sikpi; Yanhua Zhang; Mina Hassan-Zahraee; Walter Reinisch; Olaf Stuve
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071
View more
  2 in total

1.  Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity.

Authors:  Claudia Chien; Moritz Seiler; Fabian Eitel; Tanja Schmitz-Hübsch; Friedemann Paul; Kerstin Ritter
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-07-03

2.  Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy.

Authors:  Samuel Klistorner; Michael H Barnett; John Parratt; Con Yiannikas; Stuart L Graham; Alexander Klistorner
Journal:  Ann Clin Transl Neurol       Date:  2022-09-03       Impact factor: 5.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.